Article info
PDFCommentary
Choosing death in depression: a commentary on ‘Treatment-resistant major depressive disorder and assisted dying’
- Correspondence to Dr Matthew R Broome, Department of Psychiatry, University of Oxford, Oxford OX3 4JX, UK; matthew.broome{at}psych.ox.ac.uk
Citation
Choosing death in depression: a commentary on ‘Treatment-resistant major depressive disorder and assisted dying’
Publication history
- Received May 21, 2015
- Accepted May 31, 2015
- First published June 22, 2015.
Online issue publication
January 03, 2018
Article Versions
- Previous version (3 January 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Why the irremediability requirement is not sufficient to deny psychiatric euthanasia for patients with treatment-resistant depression
- Treatment-resistant major depressive disorder and assisted dying
- Drawing the line on physician-assisted death
- New use for an old drug: oral ketamine for treatment-resistant depression
- Esketamine for treatment-resistant depression
- Physician-assisted dying and two senses of an incurable condition
- Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression
- Commentary on ‘Treatment-resistant major depressive disorder and assisted dying’
- Efficacy of repetitive transcranial magnetic stimulation in treatment-resistant depression: the evidence thus far
- Why extra caution is needed in the case of depressed patients